Hepatic angiosarcoma is a mesenchymal tumor originating from liver sinusoidal endothelial cells. It is an extremely rare malignant neoplasm accounting for less than 1% of primary malignant liver tumors. The deregulated coagulopathy that can be seen in hepatic angiosarcoma fulfills the clinical diagnostic criteria of disseminated intravascular coagulation. However, the mechanism that governs this coagulopathy has been poorly understood. This case report provides histological evidence of the consumption of coagulation factors along with trapped platelets occurring within the tumor, which is the foundation for the concept of Kasabach-Merritt syndrome (KMS). KMS is characterized by thrombocytopenia and hyperconsumption of coagulation factors within a vascular tumor. However, KMS associated with angiosarcoma has not been well recognized. This case report describes, for the first time, the histological evidence of KMS that occurred in an extremely rare mesenchymal malignant tumor of the liver.
INTRODUCTION
Hepatic angiosarcoma arises from vascular endothelial cells within the liver [1] . It is believed that in the past, the malignant transformation of vascular endothelial cells was mediated or triggered by environmental or industrial toxins, such as vinyl chloride, arsenic, and thorium dioxide, however despite tighter regulations of these toxins, there is a still a constant number of reports of angiosarcoma without any such association
The clinical entity of hepatic angiosarcoma has been well known to have an extremely poor prognosis. The disease presentation typically manifests as ab dominal distension from large hepatic mass effect or by its complication of tumor rupture into abdominal cavity or intratumor bleeding. Subsequently, the average lifespan after the diagnosis has been reported to be 6 mo [2] . To date, there is no definitive or effective treatment that has been established. An attempt of surgical resection or liver transplant does not provide significant advantage in extending life as the tumor recurs in nearly all cases reported [3] . This resulted in the median life expectancy of 16 and 5 mo in partial hepatectomy and liver transplant, respectively [3, 4] . In addition, there are no wellestablished chemotherapy regimens and accordingly, this has been primarily utilized as a palliative measure [3] . The unique clinical characteristic of angiosarcoma is the pronounced dysregulation of the coagulation system seen in a subset of patients [5, 6] . This is featured by significant thrombocytopenia, prolonged prothrombin time (PT), and activated partial thromboplastin (aPTT) time with significant elevation of fibrin net degradation products, such as ddimer. These abnormalities are congruent with the diagnostic criteria of disseminated intravascular coagulation (DIC). However, the site and mechanism of the clinical feature of this abnormal coagulopathy associated with angiosarcoma have never been well explained. The clinical entity of Kasabach Merritt syndrome (KMS) is indistinguishable from DIC by bloodbased laboratory findings. The coagulopathy associated with KMS is characterized by hyperactivation of the coagulation cascade and entrapment of platelets within dilated sinusoids of the vascular tumor [7] . The concept of KMS is well described in the pediatric population with Kaposi hemangioendothelioma, and to a much lesser extent seen in giant hemangioma in the adult population [8] . Here we describe a case of primary hepatic angiosarcoma with the clinical and for the first time, histological evidence of KMS.
CASE REPORT
A 44yearold Hispanic male was admitted to our hospital for worsening abdominal pain and jaundice. Abdominal ultrasound demonstrated multiple masses with heterogeneous echogenicity (Figure 1 ). Color doppler study revealed hypervascularity within the tumors.
The patient had no significant past medical, family, or social history. He had no prior exposures to vinyl chloride, arsenic, or thorium dioxide. The physical examination was significant for scleral icterus and a distended abdomen with diffuse tenderness. The exam was negative for spider angiomata, palmar erythema, shifting dullness, hepatic bruit, caput medusae, and asterixis.
Pertinent laboratory values on admission were as follows: white blood cell count 13400/mm 3 , hemoglobin 8.8 g/dL, mean corpuscular volume 99 fL, platelets 57000/mm 3 , alkaline phosphatase 118 IU/L, total protein 5.4 g/dL, albumin 2.7 g/dL, total bilirubin 6.4 mg/dL, direct bilirubin 3.1 mg/dL, aspartate aminotransferase 42 IU/L, alanine transaminase 72 IU/L, prothrombin time 29.4 s, INR 2.88, PTT 40.7 s, fibrinogen less than 60 mg/dL, and ddimer greater than 9.999 mg/dL. Serologies for viral hepatitis and autoimmune liver disease were negative. Tumor markers such as AFP, CA 199, and CEA were all within normal limits.
Multiphase computerized tomography and magnetic resonance imaging of the abdomen revealed discrete, multifocal, and isodense masses in precontrast images involving all segments of the liver, with the largest measuring 6.5 cm (Figures 2 and 3) . Peripheral enhancement was seen in the arterial phase, but not in portal and delayed phases. Of note, there was no definite washout. These images did not demonstrate features of commonly identified hepatic malignancies, such as hepatocellular carcinoma and intrahepatic cholangiocarcinoma. The patient subsequently underwent liver needle biopsy.
The tissue demonstrated a mesenchymal tumor infiltrating the sinusoids with anastomosing, dilated vascular channels lined by atypical cells (Figure 4A ).
Immunohistochemical studies demonstrated tumor cells strongly expressed CD34, suggesting a vascular endothelial origin ( Figure 4B ). Of note, the uninvolved region showed no evidence of chronic liver disease. Based on these findings, the diagnosis of angiosarcoma was made.
DISCUSSION
In this case report we described a case of hepatic angiosarcoma in a young male with no evidence of cirrhosis and no prior history of exposure to the afo rementioned chemicals through his occupation or medical use. In addition, this patient had no history of use of anabolic steroids or conditions that were associated with the onset of angiosarcoma. Therefore, the diagnosis of idiopathic hepatic angiosarcoma was made. Consistent with other reports, this case also manifested with significant coagulopathy which is a unique feature of hepatic angiosarcoma. As described in our case, the results of the blood tests fit well into the diagnostic criteria of DIC.
Our histological investigation found increased expression of vonWillebrand factor (vWF)/factor VIII within the tumor cells, the formation of fibrin nets, and platelet aggregation within the dilated sinusoids of angiosarcoma ( Figure 4CF ). Of importance, there was no histological evidence of cirrhosis. These findings strongly suggest hyperactivation of the coagulation cascade as well as entrapment of platelets within the tumor. Therefore, our histological findings are congruent with the proposed concept of KMS. There are 72 case reports of KMS to date. Of those, 43 cases were associated with hemangioma, 16 with Kaposi hemangioendothelioma/tufted angioma, 8 with angiosarcoma, 2 with lymphangioma, 2 with angio lipoma, and 1 with Merkel cell carcinoma. These cases demonstrated marked abnormalities in coagulation and thrombocytopenia. However, none of these reports provided histological validation of KMS and therefore it remains indistinguishable from tumorassociated DIC.
Our histological investigation proposed the potential mechanism of hyperactivation of the coagulation cascade via upregulation of vWF/Factor VIII within the dilated sinusoid of the tumor. Moreover, we speculate that the upregulated vWF/Factor VIII results in the downstream formation of fibrin nets and subsequent entrapment of platelets within the tumor. Our findings highly suggest that this is the potential explanation for the significant thrombocytopenia and deregulated coagulation cascade. Thus, our report provides a con ceptual advancement for the differentiation of tumor associated DIC from the systemic manifestation of coagulopathy occurring within the vascular tumor.
In conclusion, we report a case of idiopathic hepatic angiosarcoma with features of KMS with clinical and histological evidences.
